Anteris Technologies Ltd News

Anteris Technologies Ltd: Application for quotation of securities - AVR

Sep 24 19:30 ET

Anteris Technologies Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 30 20:39 ET

Anteris Technologies Ltd: Trading Halt

Jul 21 19:58 ET

Anteris Technologies Ltd: Pause in trading

Jul 21 19:49 ET

Anteris Technologies Ltd: Anteris and v2vmedtech Announce Concept Lock for VClip

Jun 30 19:38 ET

Anteris Technologies Ltd: Change of Director's Interest Notice

Jun 25 03:38 ET

Anteris Technologies Ltd: FIH Data Confirms Optimal Valve Positioning with ComASUR

Jun 19 19:28 ET

Anteris Technologies Ltd: Update on Pivotal Trial Submission

Jun 17 19:53 ET

Anteris Technologies Ltd: Update on DurAVR Valve-in-Valve Experience

Jun 12 19:48 ET

Anteris Technologies Ltd: Data Update on First-in-Human Study of DurAVR at NY Valves

Jun 10 23:10 ET

Anteris Technologies Ltd: Notice of Annual General Meeting - Withdrawal of Resolution

May 28 03:59 ET

Anteris Technologies Ltd: First in Human TAVR in TAVR in SAVR using DurAVR

May 14 19:55 ET

Anteris Technologies Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 17 21:54 ET

Anteris Technologies Ltd: Corporate Governance Statement and Appendix 4G

Apr 14 20:19 ET

Anteris Technologies Ltd: Notice of AGM Date and Closing of Nominations for Directors

Apr 10 00:48 ET

Anteris Technologies Ltd: Trading Halt

Apr 8 20:04 ET

Anteris Technologies Ltd: Pause in trading

Apr 8 19:58 ET

Anteris Technologies Ltd: Change of Director's Interest Notice

Apr 1 17:19 ET

Anteris Technologies Ltd: Updated 30-day DurAVR THV Clinical Data

Mar 11 19:00 ET

Anteris Technologies Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jan 30 17:54 ET